The effectiveness of different-dose atorvastatin on soluble CD105,high sensitive-C reactive protein and heart rate turbulence in patients with acute coronary syndrome
10.3760/cma.j.issn.1673-4904.2011.07.005
- VernacularTitle:不同剂量阿托伐他汀治疗急性冠状动脉综合征对可溶性CD105、高敏C反应蛋白及心率震荡的影响
- Author:
Zenglei HAN
;
Yuying ZHANG
;
Qingbo CAO
;
Jinwen WANG
- Publication Type:Journal Article
- Keywords:
Coronary disease;
C-reactive protein;
Atorvastatin;
Soluble CD105;
Heart rate turbulence
- From:
Chinese Journal of Postgraduates of Medicine
2011;34(7):14-17
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effects and significance of different-dose atorvastatin on soluble CD105(sCD105),high sensitive-C reactive protein(hs-CRP)and the parameters of heart rate turbulence in patients with acute coronary syndrome(ACS). Methods One hundred and six ACS patients were divided into three groups by random digits table: control group(30 patients, routine treatment),treatment group Ⅰ(38 patients, routine treatment + atorvastatin 20 mg), and treatment group Ⅱ(38patients, routine treatment + atorvastatin 40 mg). All patients were treated for 4 weeks. The levels of serum sCD105,hs-CRP,and the parameters of heart rate turbulence before and after treatment. Results Before treatment, the levels of turbulence onset(TO), turbulence slope(TS),sCD105 and hs-CRP in three groups had no significant difference(P > 0.05). After treatment, TO,sCD105 and hs-CRP decreased significantly,and TS increased significantly(P< 0.05 or < 0.01). The change amplitude of treatment group Ⅱ was the most obvious, and the levels of above mentioned index showed significantly difference compared with that of treatment group Ⅰ[TO:(0.22 ±0.18)% vs.(0.66 ± 0.23)%;TS:(6.22 ±0.83)ms/RR interval(RRI)vs.(3.90 ±0.73)ms/RRI;sCD105:(1.65 ±0.43)mg/L vs.(2.92 ±0.50)mg/L;hs-CRP:(1.68 ±0.55)mg/L vs.(2.08±0.61)mg/L](P <0.01). Correlation analysis showed the levels of sCD105 and hs-CRP had significantly positive correlation with TO(P < 0.01)and had negative correlation with TS(P < 0.01).Conclusions The atorvastatin treatment in patients with ACS may stabilize coronary vascular endothelial cells and atherosclerotic plaque, and improve autonomic nerve function. Larger doses of atorvastatin may get more benefit.